Android app on Google Play

FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)

January 20, 2012 3:03 PM EST Send to a Friend
FDA panel votes 13-4 data on Columbia Labs' (Nasdaq: CBRX) is not sufficent on preterm birth gel.




You May Also Be Interested In


Related Categories

FDA, Hot FDA News, Trading Halts

Add Your Comment